48 related articles for article (PubMed ID: 10381335)
21. Resistance genes of aminocoumarin producers: two type II topoisomerase genes confer resistance against coumermycin A1 and clorobiocin.
Schmutz E; Mühlenweg A; Li SM; Heide L
Antimicrob Agents Chemother; 2003 Mar; 47(3):869-77. PubMed ID: 12604514
[TBL] [Abstract][Full Text] [Related]
22. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
[TBL] [Abstract][Full Text] [Related]
23. Highly efficient gene transfer into preterm CD34 hematopoietic progenitor cells.
Shields LE; Kiem HP; Andrews RG
Am J Obstet Gynecol; 2000 Sep; 183(3):732-7. PubMed ID: 10992201
[TBL] [Abstract][Full Text] [Related]
24. BCR-ABL suppresses C/EBPalpha expression through inhibitory action of hnRNP E2.
Perrotti D; Cesi V; Trotta R; Guerzoni C; Santilli G; Campbell K; Iervolino A; Condorelli F; Gambacorti-Passerini C; Caligiuri MA; Calabretta B
Nat Genet; 2002 Jan; 30(1):48-58. PubMed ID: 11753385
[TBL] [Abstract][Full Text] [Related]
25. Erythropoietin mediates terminal granulocytic differentiation of committed myeloid cells with ectopic erythropoietin receptor expression.
Arcasoy MO; Maun NA; Perez L; Forget BG; Berliner N
Eur J Haematol; 2001 Aug; 67(2):77-87. PubMed ID: 11722594
[TBL] [Abstract][Full Text] [Related]
26. Persistent low-level engraftment of rhesus peripheral blood progenitor cells transduced with the fanconi anemia C gene after conditioning with low-dose irradiation.
Kang EM; Hanazano Y; Frare P; Vanin EF; De Witte M; Metzger M; Liu JM; Tisdale JF
Mol Ther; 2001 Jun; 3(6):911-9. PubMed ID: 11407905
[TBL] [Abstract][Full Text] [Related]
27. Leridistim, a chimeric dual G-CSF and IL-3 receptor agonist, enhances multilineage hematopoietic recovery in a nonhuman primate model of radiation-induced myelosuppression: effect of schedule, dose, and route of administration.
Farese AM; Casey DB; Smith WG; Vigneulle RM; McKearn JP; MacVittie TJ
Stem Cells; 2001; 19(6):522-33. PubMed ID: 11713344
[TBL] [Abstract][Full Text] [Related]
28. Coumermycin-induced dimerization of GyrB-containing fusion proteins.
Farrar MA; Olson SH; Perlmutter RM
Methods Enzymol; 2000; 327():421-9. PubMed ID: 11045000
[No Abstract] [Full Text] [Related]
29. Oligonucleotide-mediated genetic transformation of Borrelia burgdorferi.
Samuels DS; Garon CF
Microbiology (Reading); 1997 Feb; 143 ( Pt 2)():519-522. PubMed ID: 9043127
[TBL] [Abstract][Full Text] [Related]
30. Growth control of genetically modified cells using an antibody/c-Kit chimera.
Kaneko E; Kawahara M; Ueda H; Nagamune T
J Biosci Bioeng; 2012 May; 113(5):641-6. PubMed ID: 22227120
[TBL] [Abstract][Full Text] [Related]
31. Forced dimerization increases the activity of ΔEGFR/EGFRvIII and enhances its oncogenicity.
Hwang Y; Chumbalkar V; Latha K; Bogler O
Mol Cancer Res; 2011 Sep; 9(9):1199-208. PubMed ID: 21775422
[TBL] [Abstract][Full Text] [Related]
32. Design and Applications of Bifunctional Small Molecules: Why Two Heads Are Better Than One.
Corson TW; Aberle N; Crews CM
ACS Chem Biol; 2008 Nov; 3(11):677-692. PubMed ID: 19112665
[TBL] [Abstract][Full Text] [Related]
33. A selective amplifier gene for tamoxifen-inducible expansion of hematopoietic cells.
Xu R; Kume A; Matsuda KM; Ueda Y; Kodaira H; Ogasawara Y; Urabe M; Kato I; Hasegawa M; Ozawa K
J Gene Med; 1999; 1(4):236-44. PubMed ID: 10738556
[TBL] [Abstract][Full Text] [Related]
34. Development of a modified selective amplifier gene for hematopoietic stem cell gene therapy.
Matsuda KM; Kume A; Ueda Y; Urabe M; Hasegawa M; Ozawa K
Gene Ther; 1999 Jun; 6(6):1038-44. PubMed ID: 10455406
[TBL] [Abstract][Full Text] [Related]
35. In vivo expansion of gene-modified hematopoietic cells by a novel selective amplifier gene utilizing the erythropoietin receptor as a molecular switch.
Nagashima T; Ueda Y; Hanazono Y; Kume A; Shibata H; Ageyama N; Terao K; Ozawa K; Hasegawa M
J Gene Med; 2004 Jan; 6(1):22-31. PubMed ID: 14716674
[TBL] [Abstract][Full Text] [Related]
36. Development of a novel selective amplifier gene for controllable expansion of transduced hematopoietic cells.
Ito K; Ueda Y; Kokubun M; Urabe M; Inaba T; Mano H; Hamada H; Kitamura T; Mizoguchi H; Sakata T; Hasegawa M; Ozawa K
Blood; 1997 Nov; 90(10):3884-92. PubMed ID: 9354655
[TBL] [Abstract][Full Text] [Related]
37. Granulocyte colony-stimulating factor and its receptor in normal hematopoietic cell development and myeloid disease.
van de Geijn GJ; Aarts LH; Erkeland SJ; Prasher JM; Touw IP
Rev Physiol Biochem Pharmacol; 2003; 149():53-71. PubMed ID: 12687405
[TBL] [Abstract][Full Text] [Related]
38. A G-CSF receptor-gyrase B fusion gene: A new type of molecular switch for expansion of genetically modified hematopoietic cells.
Kume A; Ito K; Ueda Y; Hasegawa M; Urabe M; Mano H; Ozawa K
Biochem Biophys Res Commun; 1999 Jun; 260(1):9-12. PubMed ID: 10381335
[TBL] [Abstract][Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
